Anti-A Antibody Rebound–Induced Thrombotic Microangiopathy After ABO-Incompatible Kidney Transplantation: A Case Report
Transplantation Proceedings · 2026-06 · 58 (5) · 854-858
DOI: 10.1016/j.transproceed.2026.03.029 ↗Kurz gefasst
Fallbericht in der Zeitschrift Transplantation Proceedings, 2026-06. Verfasst von Yukihiro Hitaka und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Graduate School of Medicine, Yamaguchi University, Ube, Yamaguchi, Japan. Electronic address: h.yukki@yamaguchi-u.ac.jp. Hauptthemen laut MEDLINE: Kidney Transplantation, ABO Blood-Group System, Thrombotic Microangiopathies, Blood Group Incompatibility. Die Arbeit nennt 18 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND ABO-incompatible kidney transplantation (ABOi-KT) expands donor availability, but postoperative anti-ABO antibody rebound can lead to rare complications such as thrombotic microangiopathy (TMA), often resulting in graft loss. CASE PRESENTATION A 61-year-old underwent ABOi-KT (A → B) after standard desensitization. Despite achieving pre-transplant anti-A IgG and IgM titers of 1:1, a marked postoperative rebound occurred, with both titers rising to 1:1024 by postoperative day 6, accompanied by TMA and acute rejection manifesting as elevated serum creatinine (sCre) (maximum 8.63 mg/dL). Notably, overt hemolytic markers and thrombocytopenia were absent. Management included intensified plasma exchange, intravenous immunoglobulin, high-dose steroids, and discontinuation of tacrolimus. sCre peaked at 8.63 mg/dL, later stabilizing to ∼5 mg/dL at 1 year without dialysis. CONCLUSIONS Despite adequate desensitization, anti-A antibody rebound can cause early TMA. Importantly, early recognition and aggressive multimodal treatment can rescue the graft, avoiding the high likelihood of graft loss. This case highlights the importance of antibody surveillance after ABOi-KT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Urology, Graduate School of Medicine, Yamaguchi University, Ube, Yamaguchi, Japan. Electronic address: h.yukki@yamaguchi-u.ac.jp.
- Department of Urology, Graduate School of Medicine, Yamaguchi University, Ube, Yamaguchi, Japan.
- Department of Urology, Molecular Oncology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan.
- Department of Pathology, Fukuoka University School of Medicine, Fukuoka, Japan.
Zitieren
APA
Hitaka, Y., Isoyama, N., Tanaka, M., Ban, Y., Ogawa, M., Yamaguchi, M., Nakamura, K., Hiroyoshi, T., Tasaki, M., Uesugi, N., & Shiraishi, K. (2026). Anti-A Antibody Rebound–Induced Thrombotic Microangiopathy After ABO-Incompatible Kidney Transplantation: A Case Report. Transplantation Proceedings, 58(5), 854-858. https://doi.org/10.1016/j.transproceed.2026.03.029
Vancouver
Hitaka Y, Isoyama N, Tanaka M, Ban Y, Ogawa M, Yamaguchi M, et al. Anti-A Antibody Rebound–Induced Thrombotic Microangiopathy After ABO-Incompatible Kidney Transplantation: A Case Report. Transplantation Proceedings. 2026;58(5):854-858. doi:10.1016/j.transproceed.2026.03.029
BibTeX
@article{Hitaka2026,
author = {Hitaka, Yukihiro and Isoyama, Naohito and Tanaka, Megumi and Ban, Yoshimasa and Ogawa, Masashi and Yamaguchi, Mitsuhiro and Nakamura, Kimihiko and Hiroyoshi, Toshiya and Tasaki, Masayuki and Uesugi, Noriko and Shiraishi, Koji},
title = {Anti-A Antibody Rebound–Induced Thrombotic Microangiopathy After ABO-Incompatible Kidney Transplantation: A Case Report},
journal = {Transplantation Proceedings},
year = {2026},
volume = {58},
number = {5},
pages = {854--858},
doi = {10.1016/j.transproceed.2026.03.029}
}
EUVIMED